(Q83694421)

English

High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer

scientific article published on 23 March 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Yumi Endo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Satoru Takahashi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hiroshi Sugiura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nobuyasu Yoshimoto

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Mai Iwasa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Shunzo Kobayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Yoshitaka Fujii

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hiroko Yamashita

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

23 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

512-518

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

https://scigraph.springernature.com/pub.10.1007/s10147-011-0215-5

0 references

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 in breast cancer: prognostic and predictive potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to exemestane as primary endocrine therapy in estrogen receptor-positive breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21431343

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-011-0215-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21431343%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83694421&oldid=2170648455"